Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.30 |
| ▸ | ADH1B | P00325 | 1/20 | 0.30 |
| ▸ | ADH1C | P00326 | 1/20 | 0.30 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL105827 | 1.00 | SHBG (0.36) | SHBGEPHX1CA1CA2ACHE | |
| SCHEMBL29255934 | 1.00 | SHBG (0.36) | SHBGEPHX1CA1CA2ACHE | |
| SCHEMBL92304 | 0.97 | — | — | |
| SCHEMBL4018245 | 0.91 | — | — | |
| SCHEMBL19773990 | 0.88 | DEGS1 (0.33) | DEGS1 | |
| SCHEMBL12227901 | 0.85 | ALDH1A1 (0.38) | SHBGDEGS1 | |
| SCHEMBL10121187 | 0.84 | DEGS1 (0.36) | DEGS1 | |
| SCHEMBL4546673 | 0.84 | — | — | |
| SCHEMBL74849 | 0.84 | DEGS1 (0.36) | DEGS1 | |
| Propylene Glycol SCHEMBL9135001 | 0.84 | TDP1 (0.42) | SHBGEPHX1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1697 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12631966-B2 | Method for forming photoresist patterns | SAMSUNG SDI CO., LTD. (KR) | 2026-05-19 | — | — | US | claimed |
| US-12590221-B2 | Resist topcoat composition, and method of forming patterns using the composition | SAMSUNG SDI CO., LTD. (KR) | 2026-03-31 | — | — | US | claimed |
| US-12554199-B2 | Resist topcoat composition, and method of forming patterns using the composition | SAMSUNG SDI CO., LTD. (KR) | 2026-02-17 | — | — | US | claimed |
| CN-116297710-A | Multifunctional pressure-gas sensor and preparation method and application thereof | 延边大学 | 2023-06-23 | — | — | CN | claimed |
| US-20230026579-A1 | METHOD FOR FORMING PHOTORESIST PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2023-01-26 | — | — | US | claimed |
| US-20230021469-A1 | RESIST TOPCOAT COMPOSITION, AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-01-26 | — | — | US | claimed |
| US-20230028244-A1 | RESIST TOPCOAT COMPOSITION, AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2023-01-26 | — | — | US | claimed |
| US-20230026721-A1 | RESIST TOPCOAT COMPOSITION, AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2023-01-26 | — | — | US | claimed |
| US-20230024422-A1 | RESIST TOPCOAT COMPOSITION, AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2023-01-26 | — | — | US | claimed |
| US-11127974-B2 | Method of preparing sulfide-based solid electrolyte, sulfide-based solid electrolyte prepared therefrom, and solid secondary battery including the sulfide electrolyte | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-09-21 | — | — | US | claimed |
| CN-102917708-A | Process for preparing macrolides and ketolides and intermediates thereof | CEMPRA PHARMACEUTICALS INC | 2013-02-06 | — | — | CN | claimed |
| CN-102766181-A | Preparation method of 6-o-substituted erythromycin derivative | SHANGHAI INST PHARM INDUSTRY | 2012-11-07 | — | — | CN | claimed |
| WO-2011146829-A1 | PROCESSES FOR PREPARING MACROLIDES AND KETOLIDES AND INTERMEDIATES THEREFOR | CEMPRA PHARMACEUTICALS, INC. (US) | 2011-11-24 | — | — | WO | claimed |
| CN-101619085-A | Erythromycin derivative and application as tumor cell proliferation inhibitor thereof | UNIV SHENYANG PHARMACEUTICAL | 2010-01-06 | — | — | CN | claimed |
| EP-1007530-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 2000-06-14 | — | — | EP | claimed |
| US-6075011-A | 6-O-substituted erythromycin compounds and method for making same | ABBOTT LABORATORIES (US) | 2000-06-13 | — | — | US | claimed |
| EP-0918783-A1 | 6-O-SUBSTITUTED ERYTHROMYCINS AND METHOD FOR MAKING THEM | ABBOTT LABORATORIES (US) | 1999-06-02 | — | — | EP | claimed |
| WO-1997042204-A1 | 6-O-SUBSTITUTED ERYTHROMYCINS AND METHOD FOR MAKING THEM | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | claimed |
| WO-1997042206-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | claimed |
| US-4990688-A | Extraction from a mixture containing an aromatic sulfonic acid using an ether/phenol extractant | BASF AKTIENGESELLSCHAFT (DE) | 1991-02-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230024422-A1 | RESIST TOPCOAT COMPOSITION, AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | TOP1, TOP2A, FTO | SHBG 1843/4885EPHX1 1030/4885CA1 345/4885 |
| US-12631966-B2 | Method for forming photoresist patterns | FTO, SOAT1, SOAT2 | SHBG 3131/4885EPHX1 1589/4885CA1 285/4885 |
| US-12554199-B2 | Resist topcoat composition, and method of forming patterns using the composition | FGFR2, FGFR1, FDFT1 | SHBG 2684/4885EPHX1 2868/4885CA1 1296/4885 |
| US-20230021469-A1 | RESIST TOPCOAT COMPOSITION, AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | COL2A1, TOP1, TOP2A | SHBG 1908/4885EPHX1 2043/4885CA1 618/4885 |
| US-12590221-B2 | Resist topcoat composition, and method of forming patterns using the composition | RER1, TOP1, RRS1 | SHBG 1213/4885EPHX1 1015/4885CA1 745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.